Misidentification

Misidentification is the error of treating one substance, plant, or fungus as another that resembles it. Unlike adulteration, nothing has been deliberately added — the held material is simply not what it is believed to be.

The error occurs across distinct supply contexts. A pressed tablet can replicate the appearance, colour, and stamp of a familiar pill while containing a different active compound. In foraging, edible and toxic species can share colouring, morphology, and habitat close enough to mislead an experienced observer. On the powder and blotter markets, structurally similar compounds may occupy a molecular profile that makes visual inspection useless and most casual testing unreliable.

Because the person handling the substance believes they know what it is, misidentification disables the caution that uncertainty would otherwise prompt.

How it is done

Several methods are used to check whether a substance matches what it is believed to be.

Reagent tests apply a colourimetric chemical to a small sample and record the colour change. Different reagents respond to different compound classes — Marquis, Mecke, Simon's, and others each produce characteristic colours for specific alkaloid families. A result is compared against a published reference chart. Fentanyl test strips, dissolved alongside a small quantity of the sample, detect fentanyl and many of its structural analogues.

Pharmaceutical matching compares a tablet's markings, dimensions, and colour against manufacturer records in published databases. The absence of any matching entry is often more useful than a match.

Morphological identification of fungi and plants draws on cap structure, gill attachment, spore print colour, bruising response, smell, and habitat. Regional field guides and expert consultation substantially improve accuracy over unaided observation. Photograph-based identification apps are widely used but carry documented error rates, particularly among toxic lookalikes.

Instrument-based analysis — gas chromatography–mass spectrometry, infrared spectroscopy, and related methods — provides the most specific identification available and is offered at some drug checking services.

What it cannot tell you

No common field identification method confirms the complete identity of a sample.

A reagent test establishes that a compound of a particular class is present. It does not distinguish between compounds within that class, cannot detect every possible substitute, and produces no signal about what else may be present alongside. A sample can return an expected colour and still contain a second active compound the test does not reach.

Pharmaceutical matching verifies a manufacturing profile, not the contents of a specific tablet. Counterfeit tablets are pressed to replicate the visual record of known pharmaceuticals precisely because a convincing match is reassuring.

Morphological identification of fungi and plants carries irreducible uncertainty. Some toxic species are visually indistinguishable from edible ones without microscopy or chemical analysis. Confidence built from repeated successful identifications does not reduce this uncertainty on any given specimen.

The failure mode shared by all these methods is the same: a reassuring result tends to be read as confirmation rather than partial evidence. What identification methods establish is probability, not identity. A result that matches expectation narrows the field of likely candidates; it does not close it.